Market Summary: The global market size for cell viability assays reached USD 3.26 Billion in 2020, with an anticipated Compound Annual Growth Rate (CAGR) of 8.7% throughout the forecast period. Key drivers fueling this growth include the increasing prevalence of chronic and infectious diseases, a growing emphasis on cell-based therapeutics, and augmented funding for cell-based research...